Dissocial personality disorder

F5_DISPER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F60.2 Hospital discharge: ICD-9 — 3017 Hospital discharge: ICD-8 — 3017 Cause of death: ICD-10 — F60.2 Cause of death: ICD-9 — 3017 Cause of death: ICD-8 — 3017 2 out of 7 registries used, show all original rules.	614
4. Check minimum number of events None	614
5. Include endpoints None	614
6. Filter based on genotype QC (FinnGen only)	614

Control definitions (FinnGen only)

Control exclude: F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F60
Name in latin: Personalitas dissocialis

NAME	F5_DISPER
CONTROL_EXCLUDE	F5_PERSOBEH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F602
HD_ICD_9	3017
HD_ICD_8	3017
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F602
COD_ICD_9	3017
COD_ICD_8	3017
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dissocial personality disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7991	1125	6739
Only index persons	6256	973	5283
Unadjusted period prevalence (%)
Whole population	0.17	0.03	0.19
Only index persons	0.18	0.04	0.20
Median age at first event (years)
Whole population	28.39	29.74	28.02
Only index persons	28.01	29.18	27.79

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	614	130	484
Unadjusted period prevalence (%)	0.18	0.04	0.21
Median age at first event (years)	29.09	31.82	28.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
571: Matched controls
5709

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F60.2

ICD-10 Finland

Dissocial personality disorder

+∞

323.0

409

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

23.7

180.0

277

218

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

160.1

146

B18.2

ICD-10 Finland

Chronic viral hepatitis C

63.0

150.1

173

T36

ICD-10 Finland

Poisoning by systemic antibiotics

33.7

149.4

199

N05AH03

ATC

olanzapine; systemic

20.8

146.3

232

182

N05BA01

ATC

diazepam; systemic, rectal

14.9

143.4

271

327

N05AA02

ATC

levomepromazine; systemic

29.9

137.2

189

N05AH04

ATC

quetiapine; oral

11.5

136.2

310

536

30170

ICD-8 Finland

Personality disorders, Antisocial

+∞

133.7

123

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

537.2

132.8

127

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

15.0

127.5

234

253

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

34.7

125.5

165

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

121.2

124.3

131

F29

ICD-10 Finland

Unspecified nonorganic psychosis

22.9

122.0

183

115

N05CD07

ATC

temazepam; oral

17.5

118.1

198

168

F60.9

ICD-10 Finland

Personality disorder, unspecified

1357.2

117.0

110

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

27.1

112.8

159

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

63.1

111.0

128

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

93.5

109.4

119

F61.0

ICD-10 Finland

Mixed personality disorders

438.5

109.3

106

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

27.1

102.5

144

N05AX08

ATC

risperidone; systemic

15.3

101.0

178

164

3017A

ICD-9 Finland

Personality disorders, Antisocial personality disorder

+∞

98.9

N05BA04

ATC

oxazepam; oral

7.6

96.1

282

648

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

12.2

94.9

188

221

N05AH02

ATC

clozapine; systemic

29.2

94.8

130

N05AF03

ATC

chlorprothixene; systemic

30.5

93.8

127

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

131.1

93.3

N06AB04

ATC

citalopram; systemic

7.4

88.3

255

558

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

99.6

85.0

F10.20

ICD-10 Finland

Alcohol dependence currently independent

25.2

83.2

119

N07BB01

ATC

disulfiram; oral

11.4

82.5

167

199

N03AG01

ATC

valproic acid; systemic, rectal

12.1

80.4

157

173

N05BA12

ATC

alprazolam; oral

9.3

74.8

171

250

P19

ICPC

Drug abuse

40.9

74.2

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

93.0

73.2

F20.9

ICD-10 Finland

Schizophrenia, unspecified

21.0

72.7

110

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

84.2

72.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.9

71.6

185

327

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

109.4

70.9

N03AE01

ATC

clonazepam; systemic

14.1

70.1

125

111

N05CF01

ATC

zopiclone; oral

5.3

69.0

279

871

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

369.7

65.9

N06AX11

ATC

mirtazapine; oral

4.9

65.1

293

1010

F10.25

ICD-10 Finland

Alcohol dependence continuous use

22.5

63.1

Z72.2

ICD-10 Finland

Drug use

67.3

62.2

N06AB03

ATC

fluoxetine; oral

7.6

62.1

161

279

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

61.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.9

59.6

149

243

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

58.3

Z2446

NOMESCO Finland

Social worker

10.4

57.6

120

143

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

133.8

57.0

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

133.8

57.0

N05AD01

ATC

haloperidol; systemic

19.1

56.5

N05AA01

ATC

chlorpromazine; systemic, rectal

30.6

56.0

N05AB03

ATC

perphenazine; systemic, rectal

14.2

53.6

N05BA02

ATC

chlordiazepoxide; systemic

18.5

52.8

P72

ICPC

Schizophrenia

18.8

51.3

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

20.5

51.0

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

86.9

49.9

N05BE01

ATC

buspirone; oral

16.3

49.8

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

50.5

49.3

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

34.1

49.2

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

83.0

47.9

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

111.8

47.6

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

136.7

47.6

N06AB06

ATC

sertraline; oral

6.3

47.4

139

276

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

81.3

46.8

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

174.3

46.6

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

27.1

45.6

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

130.7

45.5

ZY010

NOMESCO Finland

Hospital outpatient

9.8

44.6

112

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

166.4

44.5

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

19.1

44.1

P15

ICPC

Chronic alcohol abuse

10.4

44.1

101

N06AX16

ATC

venlafaxine; oral

5.2

43.7

153

373

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.2

43.3

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

25.2

43.3

N04AA02

ATC

biperiden; systemic

19.5

43.1

EBA00

NOMESCO Finland

Extraction of tooth

3.5

42.3

291

1308

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

15.5

41.3

F10.24

ICD-10 Finland

Alcohol depence active use

18.8

41.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

41.0

179

544

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

12.9

40.8

30180

ICD-8 Finland

Personality disorders, Immatura

71.3

40.7

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

56.7

40.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.1

40.0

119

237

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

51.1

39.5

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

113.1

39.3

P18

ICPC

Medication abuse

46.4

38.8

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

403.1

38.5

N03AX09

ATC

lamotrigine; oral

8.7

38.5

116

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

208.9

38.3

C07AA05

ATC

propranolol; systemic

4.2

38.1

171

528

V03AA01

ATC

15.7

37.4

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

15.7

37.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.3

37.3

N06AB10

ATC

escitalopram; oral

3.8

37.1

191

664

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.9

37.1

137

348

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

36.9

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

86.0

36.3

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

30.7

36.2

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

35.6

35.9

N05BA06

ATC

lorazepam; systemic, sublingual

9.1

35.9

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

13.5

35.7

N05AX12

ATC

aripiprazole; systemic

8.4

35.6

112

ZY000

NOMESCO Finland

Hospital inpatient

21.1

35.1

N05AN01

ATC

lithium; oral

14.8

34.9

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

69.6

34.5

A46

ICD-10 Finland

Erysipelas

4.5

34.4

136

368

N05AF05

ATC

zuclopenthixol; systemic

29.3

34.3

P29

ICPC

Psychological sympt/compl other

7.1

33.9

140

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

7.3

33.8

133

N06AA12

ATC

doxepin; systemic

10.0

33.7

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

67.7

33.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

6.7

33.3

152

AA1AD

NOMESCO Finland

CT of head and brain

3.6

33.1

178

632

F10.09

ICD-10 Finland

Alcohol intoxication UNS

11.3

32.8

RS220

NOMESCO Finland

34.7

32.7

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

65.8

32.4

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

65.8

32.4

Z3231

NOMESCO Finland

Registered nurse

3.3

32.3

202

804

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

15.7

32.1

N05AD03

ATC

melperone; systemic

35.7

31.3

F61

ICD-10 Finland

Mixed and other personality disorders

169.2

31.0

N03AX12

ATC

gabapentin; oral

4.1

30.6

134

396

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.5

30.5

201

P99

ICPC

Psychological disorders other

10.7

30.5

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

17.4

30.4

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

7.1

30.1

123

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

163.6

30.0

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

16.3

29.6

F22.0

ICD-10 Finland

Delusional disorder

20.6

29.6

F20

ICD-10 Finland

Schizophrenia

25.9

29.6

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

23.8

29.6

T74.1

ICD-10 Finland

Physical abuse

11.8

29.5

XF400

NOMESCO Finland

ECG with 12 standard connections

4.0

29.2

134

411

N05AB01

ATC

dixyrazine; systemic

22.6

29.1

S01.0

ICD-10 Finland

Open wound of scalp

5.0

29.1

100

231

F60.0

ICD-10 Finland

Paranoid personality disorder

306.8

29.0

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.0

28.9

159

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

8.9

28.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.7

28.2

104

258

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

6.6

28.2

130

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

34.8

28.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

5.3

27.8

194

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

37.2

27.7

N05CD02

ATC

nitrazepam; oral

40.0

27.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

7.0

27.3

112

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.0

27.0

214

N03AF01

ATC

carbamazepine; oral, rectal

7.1

27.0

106

A06AD11

ATC

lactulose; oral

4.6

26.9

101

255

F20.0

ICD-10 Finland

Paranoid schizophrenia

21.9

26.9

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

23.8

26.9

P01

ICPC

Feeling anxious/nervous/tense

4.5

26.4

102

265

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

+∞

26.2

Z04.6

ICD-10 Finland

General psychiatric examination, requested by authority

+∞

26.2

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

26.2

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

+∞

26.2

X78

ICD-10 Finland

Intentional self-harm by sharp object

42.3

26.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.9

26.0

204

920

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

16.9

25.8

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.0

25.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

25.7

264

1403

F99

ICD-10 Finland

Mental disorder, not otherwise specified

12.1

25.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

5.8

25.3

145

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

9.1

25.2

IGV01

NOMESCO Finland

Psychiatric network contact

24.8

25.1

SPAT1254

SPAT

Administration of medicine

4.1

24.8

105

296

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

29.1

24.7

N03AX16

ATC

pregabalin; oral

3.1

24.6

163

654

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

5.5

24.5

155

N06AB05

ATC

paroxetine; oral

5.4

24.4

160

P74

ICPC

Anxiety disorder/anxiety state

8.5

24.3

EBA30

NOMESCO Finland

Excision of root of tooth

5.8

24.3

139

SPAT1265

SPAT

Breathalyser

12.8

24.2

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

+∞

24.1

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

12.1

24.1

IGY02

NOMESCO Finland

Psychiatric monitoring contact

11.0

24.0

Z3226

NOMESCO Finland

Physiotherapist

3.5

23.9

129

445

F21

ICD-10 Finland

Schizotypal disorder

24.9

23.7

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

7.5

23.6

N05AC02

ATC

thioridazine; oral

11.8

22.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.3

22.6

127

450

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

47.1

22.5

N05CD08

ATC

midazolam; nasal, systemic

15.1

22.4

A01

ICPC

Pain general/multiple sites

5.6

22.4

135

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

54.3

22.3

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

30.5

22.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

22.0

217

1101

N06AX03

ATC

mianserin; oral

7.3

22.0

X84

ICD-10 Finland

Intentional self-harm by unspecified means

83.5

21.8

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

119.6

21.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

21.5

169

Y07

ICD-10 Finland

Other maltreatment

19.9

21.5

P16

ICPC

Acute alcohol abuse

8.7

21.1

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

7.0

21.1

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

18.7

21.1

S06.0

ICD-10 Finland

Concussion

3.7

21.0

100

311

Z2221

NOMESCO Finland

Medical doctor

2.7

21.0

176

810

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

79.9

20.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

5.5

20.8

129

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

6.2

20.6

101

N05AF01

ATC

flupentixol; systemic

18.1

20.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.1

19.9

140

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

3.6

19.9

301

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

19.7

109

379

ZXD05

NOMESCO Finland

Urgent procedure

2.5

19.7

194

968

L17

ICPC

Foot/toe symptom/complaint

2.9

19.7

139

572

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

206.9

19.7

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

206.9

19.7

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

10.1

19.7

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

10.1

19.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.8

19.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

19.4

266

1571

T51.0

ICD-10 Finland

Toxic effect: Ethanol

27.1

19.3

K08.3

ICD-10 Finland

Retained dental root

4.3

19.3

194

R02

ICPC

Shortness of breath/dyspnoea

4.0

19.2

231

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

35.7

19.0

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.4

18.9

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

29.0

18.9

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

+∞

18.9

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

72.4

18.8

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

103.5

18.7

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

10.6

18.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

10.1

18.7

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

196.2

18.6

30041

ICD-8 Finland

Neuroses, Depressiva

31.2

18.5

F31.8

ICD-10 Finland

Other bipolar affective disorders

10.9

18.4

N05CF02

ATC

zolpidem; oral

2.9

18.4

129

527

S10

ICPC

Boil/carbuncle

5.0

18.4

134

188

Kela drug reimbursment

Psychosis requiring demanding treatment

13.0

18.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

18.3

117

447

Z72.1

ICD-10 Finland

Alcohol use

12.0

18.2

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

54.4

18.1

WX110

NOMESCO Finland

Local anesthesy

2.3

18.0

429

3225

OAB43

SPAT

0.2

18.0

877

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

23.7

17.9

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

68.9

17.8

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

98.1

17.7

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

16.3

17.7

K05.31

ICD-10 Finland

Periodontitis pronounced

3.8

17.6

227

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

17.6

174

864

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.2

17.5

312

2044

SAA01

NOMESCO Finland

Simple examination of mouth

2.3

17.3

437

3337

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

17.2

220

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

13.8

17.1

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

22.7

17.0

IEV99

NOMESCO Finland

Other psychiatric network intervention

22.7

17.0

B17.1

ICD-10 Finland

Acute hepatitis C

65.4

16.8

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

13.2

16.8

30199

ICD-8 Finland

Personality disorders, Unspecified

+∞

16.7

K02.1

ICD-10 Finland

Caries of dentine

2.2

16.7

377

2709

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

92.8

16.6

F39

ICD-10 Finland

Unspecified mood [affective] disorder

9.4

16.6

A28

ICPC

Limited function/disability NOS

4.0

16.6

189

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

14.9

16.5

IGY99

NOMESCO Finland

Other psychiatric treatment contact

10.9

16.4

N06AX12

ATC

bupropion; oral

4.2

16.3

167

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

19.2

16.1

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

21.7

16.1

Z03

ICPC

Housing/neighbourhood problem

21.7

16.1

SPAT1227

SPAT

Substance abuse rehabilitation

11.7

15.9

N06AA06

ATC

trimipramine; systemic

7.8

15.7

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

+∞

15.7

F20.8

ICD-10 Finland

Other schizophrenia

27.2

15.7

SPAT1272

SPAT

Drug screening

19.9

15.7

F60.1

ICD-10 Finland

Schizoid personality disorder

87.5

15.6

30799

ICD-8 Finland

Transient situational disturbances

87.5

15.6

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

87.5

15.6

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

7.6

15.5

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

10.8

15.4

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.0

15.4

176

SPAT1240

SPAT

Therapeutic discussion

3.0

15.4

347

M79.6

ICD-10 Finland

Pain in limb

2.2

15.3

196

1090

K04.7

ICD-10 Finland

Periapical abscess without sinus

3.7

15.2

199

N05AX13

ATC

paliperidone; systemic

20.7

15.2

Z2445

NOMESCO Finland

Psychologist

4.9

15.2

109

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

12.9

15.0

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.4

15.0

153

763

SPAT1301

SPAT

No procedures

2.3

14.9

169

886

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

8.1

14.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

14.8

145

707

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

21.7

14.7

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

82.3

14.6

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

82.3

14.6

3094A

ICD-9 Finland

Adjustment reaction, With mixed disturbance of emotions and conduct

82.3

14.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.8

14.6

179

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

14.6

131

611

F60.5

ICD-10 Finland

Anankastic personality disorder

153.8

14.5

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

153.8

14.5

F90.0

ICD-10 Finland

Disturbance of activity and attention

6.6

14.5

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

37.1

14.5

S31.1

ICD-10 Finland

Open wound of abdominal wall

28.0

14.4

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

28.0

14.4

N06AX05

ATC

trazodone; oral

7.5

14.2

RS221

NOMESCO Finland

10.4

14.1

N02AX02

ATC

tramadol; systemic, rectal

2.0

14.0

242

1516

S61.9

ICD-10 Finland

Open wound of wrist and hand, part unspecified

4.9

13.9

101

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

11.8

13.9

RS310

NOMESCO Finland

54.7

13.9

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

54.7

13.9

ZXY49

NOMESCO Finland

Other health care provider

20.7

13.9

K10.3

ICD-10 Finland

Alveolitis of jaws

4.6

13.8

111

29999

ICD-8 Finland

Unspecified psychosis

77.0

13.6

WX730

NOMESCO Finland

Conventional respirator

11.3

13.6

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

11.3

13.6

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

9.7

13.6

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.8

13.6

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

+∞

13.6

30088

ICD-8 Finland

Neuroses, Other

35.0

13.6

Z3229

NOMESCO Finland

Other healthcare associate professional

3.9

13.6

153

A99

ICPC

Disease/condition unspecnature/site

4.1

13.5

138

A10BA02

ATC

metformin; oral

2.3

13.5

140

699

3092E

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]

21.8

13.4

P27

ICPC

Fear of mental disorder

8.9

13.4

R06.0

ICD-10 Finland

Dyspnoea

2.4

13.3

124

586

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

14.2

13.3

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

41.1

13.2

C07AB07

ATC

bisoprolol; oral

2.1

13.2

206

1232

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.7

13.1

168

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

11.3

13.1

SPAT1260

SPAT

Consultation of another employee

2.6

13.0

105

459

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.3

13.0

123

N06AX21

ATC

duloxetine; oral

3.2

13.0

237

L03

ICPC

Low back symptom/complaint

2.4

13.0

128

623

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

13.0

144

741

F41.09

ICD-10 Finland

UNS Panic Syndrome

6.5

12.9

A29

ICPC

General symptom/complaint other

3.5

12.9

198

-50

ICPC

Medication/prescr/renewal

5.8

12.9

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

12.9

189

1099

30899

ICD-8 Finland

Behaviour disorders of childhood

51.2

12.9

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

51.2

12.9

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

12.8

113

517

S29

ICPC

Skin symptom/complaint other

2.7

12.8

377

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.8

12.8

QCB00

NOMESCO Finland

Suture of skin of upper limb

6.9

12.7

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

71.5

12.6

P80

ICPC

Personality disorder

32.8

12.6

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

32.8

12.6

F19.51

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid

+∞

12.5

30430

ICD-8 Finland

Drug dependence, Other hypnotics and sedatives or tranquillisers

+∞

12.5

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

132.8

12.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.6

12.5

420

S76

ICPC

Skin infection other

5.1

12.5

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.9

12.4

336

2454

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

14.8

12.3

R95

ICPC

Chron obstructive pulmonary disease

14.8

12.3

SPA47

NOMESCO Finland

Precision impression for denture

14.8

12.3

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

10.0

12.3

ZYC01

NOMESCO Finland

Remote contact by phone

4.5

12.3

105

F34.1

ICD-10 Finland

Dysthymia

5.7

12.3

TKC20

NOMESCO Finland

Catheterisation of bladder

4.1

12.3

125

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

12.3

147

778

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

38.4

12.3

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

38.4

12.3

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

7.2

12.2

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

18.5

12.1

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

192

106

25.90

250.96

9.1

4.4

—

(3011288) Drugs identified in Urine by Screen method

212

196

15.99

210.08

13.5

3.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

213

239

13.11

184.60

9.2

2.6

—

(3016879) Cocaine [Presence] in Urine

218

294

10.95

163.82

9.9

2.4

—

(3000764) Benzodiazepines [Presence] in Urine

221

320

10.23

156.48

10.0

2.3

—

(3028300) Cannabinoids [Presence] in Urine

221

324

10.09

154.79

10.0

2.2

—

(3027008) Opiates [Presence] in Urine

220

324

10.02

153.41

9.0

2.3

—

(3027944) Amphetamines [Presence] in Urine

216

320

9.87

149.61

8.6

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

29.82

137.66

2.1

1.6

—

(4198724)

33.86

130.34

5.5

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

59.11

95.65

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

12.68

85.99

8.4

5.3

umol/l

411.3

359.1

1.13

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

19.09

73.11

8.2

2.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

276

953

4.44

71.45

3.5

2.0

1.7

1.4

5.90

240

871

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

378

1678

4.26

68.08

5.1

3.8

u/l

58.4

34.6

1.18

358

1603

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

437

2254

4.26

61.07

6.4

7.0

umol/l

10.1

11.7

2.16

412

2164

(3009508) Creatinine [Moles/volume] in Urine

316

1318

3.88

60.44

9.2

3.5

mmol/l

7.6

9.3

6.62

266

1141

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

344

1632

3.52

51.75

8.5

6.9

mmol/l

1.2

1.59

318

1520

(3024561) Albumin [Mass/volume] in Serum or Plasma

349

1687

3.48

50.61

4.8

5.9

g/l

35.2

36.9

5.99

329

1598

(3019150) Specific gravity of Urine by Refractometry

234

898

3.59

48.82

6.9

3.2

kg/l

1.0

0.45

115

(3023368) Bacteria identified in Blood by Culture

264

1097

3.47

48.50

6.1

4.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

7.68

45.83

2.2

4.6

umol/l

34.8

36.8

0.24

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

355

1816

3.26

45.29

8.4

7.7

mmol/l

1.2

1.62

308

1565

(3013650) Neutrophils [#/volume] in Blood by Automated count

444

2603

3.55

44.81

25.1

9.9

e9/l

4.4

4.0

2.89

405

2299

(46235355) HIV 1 and 2 tests - Meaningful Use set

262

1132

3.29

44.39

2.3

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

139

6.28

43.00

2.2

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

518

3425

4.28

41.74

8.9

7.9

u/l

79.6

76.6

1.14

500

3262

(40758558) Short blood count panel - Blood

248

1074

3.20

41.29

13.4

7.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

173

605

3.59

40.76

2.1

1.8

—

(3006315) Basophils [#/volume] in Blood

401

2300

3.14

40.15

10.4

6.5

e9/l

0.0

0.38

357

2033

(3003396) Base excess in Arterial blood by calculation

143

445

3.89

40.04

10.0

10.1

mmol/l

1.5

0.9

0.88

118

352

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

141

435

3.91

39.96

2.1

1.8

—

(3013115) Eosinophils [#/volume] in Blood

408

2374

3.14

39.60

12.2

6.8

e9/l

0.2

0.22

369

2136

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

141

441

3.85

39.12

2.1

1.8

—

(3001604) Monocytes [#/volume] in Blood

398

2299

3.08

38.85

10.6

6.4

e9/l

0.6

2.59

358

2029

(3021447) Carbon dioxide [Partial pressure] in Venous blood

126

368

4.05

38.49

4.2

3.5

kpa

6.1

5.8

1.08

120

358

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

140

447

3.76

37.58

10.2

10.0

kpa

5.5

5.2

2.63

135

422

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

209

859

3.17

37.48

2.0

1.6

—

(3002032) Base excess in Venous blood by calculation

124

366

3.99

37.25

4.3

3.5

mmol/l

1.4

1.9

0.47

297

(3018418) pH of Serum or Plasma

238

1059

3.04

37.07

3.9

4.5

7.4

0.89

201

(3019198) Lymphocytes [#/volume] in Blood

402

2376

3.00

36.86

10.8

6.5

e9/l

2.2

1.9

6.80

361

2138

(42870588) Differential panel, method unspecified - Blood

296

1490

2.90

36.66

7.8

6.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

106

299

4.08

33.74

4.0

2.7

kpa

5.0

4.8

0.47

100

291

(3013826) Glucose [Moles/volume] in Serum or Plasma

414

2571

2.87

33.05

8.5

5.1

mmol/l

6.7

0.01

395

2408

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

122

401

3.55

30.95

5.0

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

267

1371

2.68

30.45

3.8

2.8

u/l

51.2

56.1

1.09

246

1301

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

117

378

3.59

30.45

2.1

2.6

g/l

0.2

1.11

100

350

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

271

1405

2.66

30.27

1.9

1.7

pmol/l

92.9

95.6

0.41

149

801

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

13.92

29.85

2.4

1.7

umol/l

132.8

128.4

—

(3000991) Gas panel - Venous blood

112

359

3.59

29.45

11.5

9.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

174

735

2.91

28.73

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

232

1139

2.67

28.61

6.3

4.1

90.7

91.7

0.27

222

1122

(3031040) Bacteria [#/volume] in Urine by Automated count

398

2548

2.60

27.75

5.0

3.5

e6/l

46.8

327.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

126

5.17

27.49

1.4

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

7.57

27.43

1.8

1.6

promille

1.1

1.5

0.78

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

244

1249

2.58

27.38

3.4

2.1

u/l

576.8

221.0

1.07

230

1194

(3019069) Monocytes/100 leukocytes in Blood

356

2172

2.52

27.38

9.6

6.7

8.2

8.8

3.21

339

2081

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

197

4.26

26.90

4.6

3.2

mmol/l

23.4

24.2

1.04

183

(3007853) Bacteria identified in Skin by Aerobe culture

137

529

3.05

26.38

2.2

1.6

—

(3022096) Basophils/100 leukocytes in Blood

344

2098

2.45

26.01

9.2

6.5

0.6

0.7

4.70

328

1999

(3008152) Bicarbonate [Moles/volume] in Arterial blood

233

3.91

25.58

8.3

9.8

mmol/l

25.4

24.5

1.30

215

(3019309) Folate [Moles/volume] in Red Blood Cells

135

526

3.01

25.52

1.8

1.6

nmol/l

1181.0

1172.5

0.03

106

417

(3006504) Eosinophils/100 leukocytes in Blood

348

2152

2.42

25.24

9.3

6.5

2.7

2.9

1.37

331

2050

(3018010) Neutrophils/100 leukocytes in Blood

356

2225

2.43

25.19

9.3

6.2

55.9

56.6

0.49

338

2130

(3002030) Lymphocytes/100 leukocytes in Blood

359

2255

2.43

25.08

9.6

6.4

28.9

28.5

0.28

341

2152

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

123

461

3.09

24.85

9.1

5.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

234

3.84

24.65

1.7

1.4

—

(1761868) Lipid panel - Serum or Plasma

108

2358

0.34

23.57

3.4

2.5

—

(3042517) Benzodiazepines panel - Urine

48.75

23.51

5.1

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

217

3.86

23.49

1.5

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

260

1455

2.36

23.14

3.4

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

163

736

2.65

23.10

1.7

1.5

nmol/l

16.8

20.3

2.91

148

653

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

146

4.45

22.97

2.6

2.3

ug/l

359.0

337.2

0.07

139

(3012095) Magnesium [Moles/volume] in Serum or Plasma

154

683

2.67

22.57

3.2

4.2

mmol/l

0.8

1.23

143

651

(3032080) INR in Blood by Coagulation assay

279

1626

2.31

22.41

5.2

7.7

inr

1.1

1.2

2.33

484

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

113

432

2.98

21.88

3.0

2.9

u/l

27.5

152.7

0.62

384

(3030467) Casts [#/volume] in Urine by Automated count

212

1111

2.39

21.65

3.3

2.9

e6/l

0.5

0.3

0.24

158

816

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

209

3.71

20.95

1.9

1.5

—

(3021589) Normoblasts [#/volume] in Blood

321

2024

2.23

20.85

15.3

9.0

e9/l

0.0

0.31

268

1656

(3026008) Bacteria identified in Urine by Culture

160

749

2.54

20.81

3.5

2.6

—

(3020891) Body temperature

149

4.19

20.67

6.9

4.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

121

496

2.79

20.52

1.8

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

128

542

2.72

20.38

5.2

7.8

mmol/l

1.0

0.01

123

519

(3019060) Gas panel - Arterial blood

249

3.44

20.35

5.8

7.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

181

911

2.40

20.01

3.4

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

222

1228

2.27

19.63

3.3

3.0

e6/l

36.1

96.7

0.54

166

939

(36304419) Bacteria [Presence] in Urine

206

1107

2.30

19.50

3.3

2.8

—

(3018095) Leukocytes [#/volume] in Urine

246

1422

2.22

19.50

3.7

3.5

e6/l

26.9

95.9

1.31

174

1009

(3015377) Calcium [Moles/volume] in Serum or Plasma

217

1206

2.24

18.82

2.7

3.5

mmol/l

2.3

2.4

0.14

194

1090

(21494755) Public health laboratory ask at order entry panel

933

0.11

18.48

1.3

1.4

—

(3042936) Bacteria identified in Isolate by Culture

137

632

2.50

18.15

2.3

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

144

682

2.45

18.01

2.5

2.6

e6/l

1.0

0.9

0.08

370

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

438

3245

2.22

17.59

4.5

3.3

pmol/l

14.7

0.02

409

3017

(3000850) Epithelial cells [#/volume] in Urine

161

814

2.33

17.31

2.8

2.5

e6/l

6.1

3.2

1.81

144

722

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

4.31

16.61

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

224

3.23

16.16

14.4

11.7

mmol/l

24.5

24.4

0.10

213

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

513

4127

2.48

15.90

5.5

3.7

mu/l

1.7

2.1

0.65

474

3869

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

789

0.11

15.42

1.2

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

4.28

15.40

1.2

1.1

—

(40761535) Cells panel - Urine sediment

287

2.88

14.82

3.0

3.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

569

4899

3.20

13.86

26.8

12.7

mmol/l

139.1

139.7

6.08

556

4782

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

236

2.96

13.59

10.8

13.5

—

(3026782) Osmolality of Urine

146

776

2.16

13.54

2.9

2.6

mosm/kgh2o

482.5

596.2

6.22

130

676

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

533

0.14

13.51

1.3

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

114

548

2.33

13.49

3.1

3.3

umol/l

8.1

7.9

0.04

491

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

154

837

2.12

13.48

2.1

2.0

mg/l

3.2

2.9

0.55

139

733

(3020779) Urea [Moles/volume] in Serum or Plasma

390

2.53

13.38

6.2

9.8

mmol/l

7.4

8.5

0.96

377

(1616796) Gas panel - Central venous blood

4.19

13.27

4.2

3.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

569

4923

3.13

13.25

26.5

12.8

mmol/l

4.0

0.51

556

4802

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

483

3898

2.12

13.09

6.8

3.2

u/l

62.2

51.2

1.99

459

3748

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

126

644

2.20

12.84

2.6

2.7

e6/l

1.3

1.1

0.18

334

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

146

804

2.07

12.22

4.6

3.4

ng/l

324.9

741.6

0.86

582

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

4.82

11.99

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

267

0.00

11.02

0.0

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

562

4925

2.67

10.97

22.9

11.8

mg/l

27.1

23.6

1.59

488

3805

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

6.15

10.44

4.3

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

176

1087

1.87

10.35

4.2

3.3

estimate

0.0

0.69

374

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

237

1616

1.76

9.97

2.3

2.2

nmol/l

68.8

72.4

1.12

216

1503

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.28

9.77

1.1

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

4.34

9.45

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

408

3264

1.75

9.42

3.3

3.8

mm/h

13.1

8.7

5.23

373

3085

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1358

0.45

9.37

2.0

2.4

ug/l

0.6

0.7

0.17

694

(3052851) Hemolysis interference index of Serum or Plasma

115

3.26

9.34

3.6

3.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

108

584

2.03

9.31

2.6

3.3

mmol/l

2.4

1.15

509

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

273

2.46

9.31

2.0

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

180

2.74

8.90

1.2

1.4

miu/ml

162.2

212.5

0.29

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

746

0.29

8.86

1.3

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

375

2959

1.69

8.83

4.6

3.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

125

725

1.91

8.78

1.5

1.6

pmol/l

436.2

18051543.2

0.76

109

626

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

122

703

1.92

8.73

1.8

2.0

—

(3003181) Sodium [Moles/volume] in Urine

4.49

8.67

1.4

1.3

mmol/l

67.3

58.3

0.18

(3009261) Glucose [Presence] in Urine by Test strip

290

2149

1.66

8.63

3.6

3.0

estimate

0.1

0.0

0.49

357

(3024928) Oxygen saturation in Venous blood

3.38

8.59

3.7

2.8

—

(3012501) Base excess in Blood by calculation

3.41

8.45

6.2

4.2

mmol/l

3.1

2.5

0.43

(3021601) Nitrite [Presence] in Urine by Test strip

288

2140

1.65

8.41

4.5

4.2

estimate

0.0

0.00

392

(3020682) Albumin/Creatinine [Ratio] in Urine

183

1209

1.73

8.32

3.9

4.3

mg/mmol

10.4

0.00

120

825

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.53

8.31

1.6

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.53

8.31

1.6

1.2

—

(3012516) Albumin [Mass/volume] in Urine

175

1142

1.74

8.31

3.1

3.5

mg/l

369.6

290.8

0.09

118

784

(3021901) Oxygen saturation in Capillary blood

3.79

8.25

2.4

2.1

—

(3017509) Phencyclidine [Presence] in Urine

14.72

8.23

1.5

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

427

2.09

8.15

11.6

18.5

inr

1.1

1.3

0.85

(3010421) pH of Blood

109

3.14

8.13

6.3

4.1

7.4

0.75

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

158

1007

1.77

8.13

2.7

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

194

1311

1.70

8.09

2.8

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

128

780

1.81

7.61

2.0

—

(3044889) 12 lead EKG panel

400

3276

1.63

7.55

4.7

3.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

104

596

1.90

7.51

2.1

2.5

umol/l

11.3

14.9

5.50

562

(3035350) Ketones [Presence] in Urine by Test strip

284

2146

1.60

7.47

3.8

3.0

estimate

0.0

0.39

380

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

344

2.13

7.34

3.1

2.0

ug/l

6.7

11.2

1.00

321

(3007566) Smooth muscle Ab [Titer] in Serum

163

2.62

7.25

1.1

1.4

titre

77.8

60.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

169

1136

1.67

7.05

10.9

4.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

553

1.87

6.80

2.2

2.5

g/l

2.4

2.3

0.75

521

(3008402) Methanol [Moles/volume] in Serum or Plasma

16.92

6.76

1.2

1.0

mmol/l

—

(40767503) Oxygen content in Capillary blood by calculation

3.33

6.62

3.2

2.3

16.6

17.4

0.34

(3000494) Fungus identified in Specimen by Culture

566

1.85

6.59

1.4

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

485

4232

1.70

6.55

36.2

14.1

13.9

13.5

10.25

478

4151

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

3.37

6.47

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

261

2.17

6.22

1.7

3.3

e9/l

76.4

73.0

0.29

191

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

518

1.84

6.09

2.2

2.6

21.1

25.4

1.55

462

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

2.93

6.01

6.4

4.5

57.5

55.9

0.24

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.36

5.91

1.4

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

258

1984

1.52

5.85

4.2

3.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.94

5.85

2.2

1.7

—

(3008295) Osmolality of Serum or Plasma

3.68

5.80

1.2

1.3

mosm/kgh2o

279.8

285.6

0.25

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

139

933

1.63

5.70

2.5

3.1

ng/l

683.9

1041.0

0.79

116

760

(3030905) Polymorphonuclear cells [#/volume] in Blood

2.88

5.63

6.0

4.0

e9/l

4.6

4.2

0.28

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

100

2.78

5.50

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

558

1.74

5.22

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

169

1212

1.54

5.18

1.7

mmol/l

1.9

1.5

2.22

149

1050

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

126

1788

0.63

5.09

3.5

3.2

22.2

21.4

0.16

630

(3013512) EKG study

149

1065

1.53

4.58

4.0

3.3

—

(4010399)

302

1.90

4.52

1.5

—

(3009343) pH of Capillary blood

267

1.95

4.46

2.7

2.9

7.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

254

1.97

4.39

2.7

3.0

mmol/l

2.3

1.4

0.79

182

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

128

2.33

4.19

1.6

1.7

—

(40761536) Microorganisms panel - Urine sediment

355

1.80

4.19

4.5

3.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

223

2.00

4.17

1.6

1.5

mu/l

513.6

268.2

1.32

208

(3026389) Candida sp identified in Specimen by Organism specific culture

3.80

4.10

1.4

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

365

1.78

4.10

5.4

4.7

0.8

0.9

0.28

112

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

246

1.94

4.10

3.0

3.7

pmol/l

4.5

4.8

1.10

224

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

111

2.40

4.05

1.3

2.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

112

2.38

3.97

1.3

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.35

3.87

1.5

1.9

umol/l

14.1

21.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

326

1.79

3.85

2.5

2.2

ml/min/173m2

64.3

72.7

0.60

133

(44790049)

2.89

3.82

1.4

2.0

—

(44806118)

2.89

3.82

1.4

2.0

—

(44790048)

2.89

3.82

1.4

2.0

—

(44790047)

2.89

3.82

1.4

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

225

1794

1.40

3.82

2.7

ug/l

124.0

154.1

1.31

212

1697

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

3.58

3.78

1.9

2.9

79.1

94.4

0.72

(3004588) Protein electrophoresis panel - Serum or Plasma

207

1.94

3.57

2.2

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

489

4469

1.46

3.53

6.4

4.8

mmol/mol

40.0

39.3

0.65

463

4265

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

206

1642

1.38

3.43

5.1

3.0

ng/l

33.5

59.5

0.86

154

998

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

2.34

3.30

1.8

2.6

—

1340.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

139

1043

1.43

3.26

1.9

1.8

mg/l

1.5

1.0

1.17

107

774

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.48

3.24

1.7

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.38

3.20

1.5

1.2

—

(1002224) Polysomnography panel

358

0.40

3.19

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2.45

3.16

1.2

2.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.00

3.15

1.0

1.3

—

356.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

411

1.62

3.11

2.1

nmol/l

360.1

359.9

0.00

383

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

2.94

0.0

1.1

—

0.9

—

(3045788) Cell count panel - Pleural fluid

4.14

2.89

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

3.95

2.78

1.9

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

265

1.71

2.74

1.5

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

502

4683

1.39

2.60

18.9

10.3

ml/min/173m2

95.7

90.0

7.10

426

3860

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

2.22

2.60

2.8

4.5

u/ml

9108.8

3.4

0.48

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.93

2.59

4.2

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.04

2.57

1.3

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

4.04

2.57

1.0

4.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

2.04

2.54

1.2

1.6

ug/g

285.3

267.5

0.15

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

503

4699

1.39

2.54

5.7

3.7

mmol/l

6.4

5.9

6.29

470

4406

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.35

2.50

1.3

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.85

2.48

3.5

3.9

—

(3025159) Blasts/100 leukocytes in Blood

330

1.59

2.44

6.3

4.8

0.0

0.3

1.45

(3019832) Treponema pallidum Ab [Presence] in Serum

521

1.48

2.43

1.5

1.9

—

(3037121) Protein [Mass/volume] in Urine

155

1.84

2.33

2.5

4.0

g/l

0.1

0.2

2.24

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

1.97

2.33

2.9

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

344

1.56

2.28

5.7

4.4

0.6

0.01

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

159

1.80

2.17

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

203

1708

1.28

2.16

4.3

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.32

2.15

1.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.32

2.15

1.0

2.6

—

(3044290) Cell count panel - Cerebral spinal fluid

2.08

2.13

2.9

1.3

—

(3011648) Oxygen content in Venous blood

2.59

2.10

1.6

1.5

10.3

12.1

0.59

(40768806) Pleura Pathology biopsy report

3.23

2.10

1.6

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

175

0.39

2.06

1.1

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

328

1.54

2.06

1.6

2.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.53

2.06

1.1

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.53

2.06

1.1

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

1.81

2.00

2.6

3.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

564

5423

1.49

1.99

15.2

9.3

u/l

40.4

32.6

3.82

550

5302

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

113

1.89

1.94

2.4

3.3

u/ml

0.4

0.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

3.78

1.94

1.5

1.1

u/l

22.7

9.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

279

0.49

1.93

1.6

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

2.18

1.89

1.2

1.7

—

(3037756) Immunofixation for Serum or Plasma

2.33

1.88

1.4

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

1.87

0.0

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.87

0.0

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

130

1.80

1.84

2.9

3.2

u/l

1190.0

1175.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

485

5094

0.77

1.81

4.8

3.9

mmol/l

4.3

4.8

15.67

448

4854

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.78

1.79

2.0

2.8

33.4

34.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

484

5082

0.78

1.77

4.6

3.9

mmol/l

1.2

1.3

16.52

448

4831

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.11

1.77

1.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.46

1.76

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.46

1.76

1.1

1.0

—

(3003338) MCHC [Mass/volume]

491

4643

1.29

1.73

38.9

13.9

g/l

333.1

335.7

7.88

484

4616

(3037522) Nuclear Ab [Titer] in Serum

618

1.36

1.73

1.2

1.4

titre

306.7

345.6

—

117

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

2.94

1.72

1.4

1.3

u/l

1007.9

298.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.87

1.72

4.2

1.4

—

(3035880) pH of Pleural fluid

3.87

1.72

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.03

1.71

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.60

1.66

1.0

1.5

nmol/l

173.6

162.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

345

1.46

1.66

6.3

4.7

0.0

0.2

3.76

105

(3019225) pH of Specimen

321

1.47

1.63

2.9

4.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.17

1.62

1.1

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.35

1.61

1.1

—

(3044941) Cell count panel - Synovial fluid

2.13

1.56

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.35

1.52

1.6

4.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.35

1.52

5.6

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.35

1.52

4.8

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

1.51

0.0

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

101

1.81

1.50

2.9

1.2

e6/l

6.5

18.8

0.66

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

101

1.81

1.50

2.9

1.3

e6/l

3570.8

2384.5

0.12

(3015183) Erythrocyte sedimentation rate

0.00

1.50

0.0

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

163

1.62

1.48

1.3

1.8

—

277.1

—

(3023410) Appearance of Cerebral spinal fluid

2.39

1.46

3.1

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.14

1.44

1.8

1.7

u/l

11.8

15.6

—

(3025130) Human papilloma virus identified in Specimen

2.33

1.43

1.8

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

111

1.73

1.40

2.4

1.9

iu/l

3.6

5.3

—

(3016018) Differential panel - Cerebral spinal fluid

2.27

1.40

3.2

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

199

2252

0.83

1.40

3.3

3.4

ug/l

5.8

1.7

0.46

166

2080

(3036489) Thrombin time

182

1.56

1.39

1.6

2.4

21.8

21.5

0.12

162

(3022145) Colonoscopy Study observation

533

0.69

1.38

1.3

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1.82

1.38

2.2

3.5

mg/l

17.5

24.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.21

1.37

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

470

4915

0.81

1.35

4.2

3.6

mmol/l

1.8

1.4

5.11

434

4665

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

1.34

0.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.16

1.34

1.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

160

1.59

1.33

1.0

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

1.33

0.0

1.3

—

0.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.37

1.29

1.1

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.98

1.22

1.4

1.8

—

(4281824)

2.64

1.22

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.18

1.21

2.0

1.6

—

(4094501)

145

0.48

1.21

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.85

1.20

1.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

165

1.54

1.19

1.9

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.02

1.17

1.4

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

3.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

152

0.52

1.15

1.1

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.06

1.15

1.4

1.8

—

(40768441) Liver Pathology biopsy report

2.06

1.15

2.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.15

1.4

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.15

1.4

1.8

—

(36660697) Celiac disease serology panel - Serum

363

1.35

1.14

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

112

0.44

1.14

1.0

1.5

—

(3008898) HLA-B27 [Presence]

231

0.60

1.11

1.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

109

921

1.22

1.10

1.3

1.4

g/l

2.3

2.5

0.82

632

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.75

1.09

1.0

1.7

—

(4024509)

2.39

1.09

1.2

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

498

5147

0.83

1.03

5.1

4.2

mmol/l

2.6

2.9

13.63

461

4888

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

140

1.52

0.98

2.0

1.8

—

(40761511) CBC panel - Blood by Automated count

545

5301

1.25

0.98

22.2

10.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.98

0.0

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.66

0.95

1.4

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.90

0.94

1.1

3.6

—

(3045414) Leukocytes [Presence] in Urine

167

1.45

0.93

1.4

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

1.49

0.91

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

1.51

0.89

2.0

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

144

1.47

0.88

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

144

1.47

0.88

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.01

0.87

3.5

1.2

—

(3000330) Specific gravity of Urine by Test strip

153

1.45

0.87

1.8

3.2

—

(3022621) pH of Urine by Test strip

230

1.37

0.86

2.1

2.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.73

0.86

1.3

1.7

—

(3021788) Differential panel - Synovial fluid

1.70

0.83

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

340

1.28

0.80

3.3

2.4

e9/l

4.4

4.2

0.34

295

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

0.60

0.80

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.79

0.0

1.7

—

127.0

—

(4133840)

0.00

0.79

0.0

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.79

0.0

1.3

—

190.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

234

1.34

0.79

2.9

4.8

ng/l

75.2

92.6

0.53

217

(3041096) Erythrocytes [Presence] in Urine by Automated

113

1280

0.86

0.77

3.5

2.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.77

0.76

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

1.85

0.73

2.4

1.4

—

(44813793)

2.01

0.73

1.2

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.59

0.72

1.2

3.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1.56

0.70

2.7

2.1

—

46.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.86

0.68

1.0

1.1

iu/ml

228.0

191.5

—

(40768804) Tissue Pathology biopsy report

148

1627

0.88

0.67

2.0

1.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.79

0.66

1.0

2.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.79

0.66

1.8

3.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

154

0.64

0.65

1.0

1.1

—

2.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

101

0.59

0.62

1.2

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

103

0.58

0.62

1.8

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.60

0.0

2.1

—

4.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.60

0.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.57

0.59

1.6

2.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.58

0.0

1.0

—

28.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

222.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.58

0.0

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

5.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

870.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

116

1283

0.88

0.58

2.2

2.5

umol/l

351.9

4585.8

3.20

1175

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.49

0.57

2.3

2.0

—

729.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

112

1008

1.14

0.57

1.4

1.2

u/ml

0.7

2.0

1.54

290

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.56

1.0

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.55

0.56

1.0

1.1

—

4.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.55

1.4

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.58

0.54

1.5

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

373

3866

0.91

0.52

3.4

3.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.62

0.52

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.62

0.52

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.62

0.52

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.62

0.52

1.2

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.47

0.50

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

487

4977

0.90

0.49

32.1

11.9

40.0

42.2

4.91

313

4141

(3035285) Chloride [Moles/volume] in Venous blood

1.46

0.47

2.0

2.6

mmol/l

103.6

105.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.46

0.47

2.0

2.6

—

(3041354) Potassium [Moles/volume] in Venous blood

1.46

0.47

2.0

2.6

mmol/l

4.1

4.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.43

0.46

2.6

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.43

0.46

1.0

1.3

—

(4034850)

157

1.28

0.44

21.0

7.9

—

(3036603) Volume of Urine

1.62

0.43

1.8

1.6

—

1572.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.43

0.42

1.0

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.64

0.42

1.2

—

(3023419) Bacteria identified in Sputum by Culture

1.38

0.41

1.9

3.0

—

(21494434) Karyotype in Bone marrow

1.52

0.41

1.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.52

0.41

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.0

—

105.7

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.41

0.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

27.9

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.41

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.1

—

112.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.0

—

91.9

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.41

0.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

17.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

104.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

3.2

—

15.7

—

(3022313) Gas panel - Capillary blood

195

1.24

0.41

3.2

3.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

138

0.72

0.41

1.0

2.3

mg/l

8.9

10.9

—

132

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.40

0.0

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.40

0.0

2.1

—

45.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.40

0.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.40

0.0

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

334

0.83

0.39

2.2

2.3

—

21.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

312

0.83

0.39

1.2

—

34.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.39

0.38

1.2

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.35

0.37

1.2

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

729

1.11

0.36

1.2

iu/ml

44.0

27.0

0.32

244

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.63

0.35

1.0

1.2

—

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

144

1.26

0.35

1.3

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

625

0.89

0.35

2.2

2.8

ug/g

85.2

145.8

2.21

526

(3007461) Platelets [#/volume] in Blood

581

5759

1.16

0.33

42.7

16.5

e9/l

240.2

246.4

1.37

568

5633

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.69

0.33

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

1.28

0.32

1.7

4.0

—

(3000492) Spirometry study

651

0.90

0.31

1.3

1.4

—

(4062490)

1.25

0.29

1.3

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.25

0.29

1.0

1.5

nmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

807

1.09

0.29

2.7

2.3

nmol/l

13.8

14.6

0.32

749

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

470

1.12

0.28

4.4

3.8

26.5

29.6

1.24

348

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

1.27

0.28

1.2

1.4

—

(3024731) MCV [Entitic volume]

581

5767

1.14

0.26

42.5

16.4

90.6

90.2

1.15

574

5707

(3035941) MCH [Entitic mass]

581

5767

1.14

0.26

42.4

16.4

30.3

0.58

574

5707

(3026361) Erythrocytes [#/volume] in Blood

581

5768

1.14

0.26

42.6

16.4

e12/l

4.6

4.7

6.53

566

5644

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.66

0.26

1.4

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

581

5769

1.13

0.25

42.9

16.5

g/l

138.2

143.3

11.20

574

5707

(3010813) Leukocytes [#/volume] in Blood

581

5770

1.13

0.24

43.0

16.5

e9/l

7.7

6.6

24.53

566

5642

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.74

0.24

1.0

1.2

—

19.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

143

1.19

0.23

1.3

2.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.32

0.23

1.6

1.0

—

(3051651) Icteric interference index of Serum or Plasma

1.28

0.23

1.8

4.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

100

1056

0.94

0.22

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.22

0.22

1.0

—

(40768443) Skin Pathology biopsy report

163

1.17

0.22

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

5.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.21

0.0

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.21

0.0

4.1

—

5438.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(4038314)

0.00

0.21

0.0

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

9.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.21

0.0

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.16

0.21

1.4

2.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.25

0.20

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

313

0.89

0.20

1.1

1.3

u/ml

76.1

343.2

2.63

289

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.22

0.19

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

279

1.12

0.19

1.4

1.2

iu/ml

103.2

136.4

—

109

(3002256) Pathology report gross observation

511

1.08

0.19

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.18

0.19

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

156

1.16

0.18

2.7

3.2

mg/l

1.8

1.4

0.78

149

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.72

0.17

7.0

4.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

264

1.10

0.16

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

1.14

0.16

1.4

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.10

0.15

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.81

0.14

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

519

0.94

0.13

1.7

1.5

—

(4035726)

309

1.07

0.10

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.15

0.09

1.3

u/ml

1.6

5.0

—

(3003694) ABO and Rh group [Type] in Blood

133

1361

0.97

0.09

1.3

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.11

0.09

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

684

0.96

0.09

1.2

u/ml

21.7

9.5

0.31

315

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.09

0.09

1.0

1.1

—

(4268621)

1.03

0.08

2.7

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.03

0.08

1.0

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.80

0.08

1.0

1.1

mg/l

284.2

262.9

—

(3045424) Erythrocytes [Presence] in Urine

1.14

0.08

1.6

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

137

1.10

0.07

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.05

0.07

2.5

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.84

0.07

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.07

0.07

2.8

3.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

157

1.09

0.07

1.1

1.3

—

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

128

1.10

0.06

1.3

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

132

0.91

0.06

2.1

2.4

ug/min

50.3

121.8

—

(4306422)

1.11

0.05

1.1

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

364

0.96

0.05

2.1

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

250

1.04

0.03

1.2

1.3

—

(3025941) Bacteria identified in Stool by Culture

271

1.03

0.02

1.5

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

248

0.97

0.02

1.3

1.4

u/l

9.7

5.9

0.57

203

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

124

1.05

0.00

1.3

1.5

u/ml

104.1

98.2

—

(3049717) Cytology report of Urine Cyto stain

134

1.05

0.00

2.0

2.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

0.98

0.00

1.4

1.6

iu/ml

0.0

0.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

203

0.98

0.00

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

247

1.01

0.00

1.1

1.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

2.4

—

53.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

10.0

—

0.4

—

(4015189)

0.00

0.0

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.94

0.00

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

13.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.0

4.0

—

200.6

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

202.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.91

0.00

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.91

0.00

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

3.4

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.1

—

64.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.89

0.00

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.00

0.00

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.88

0.00

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.91

0.00

1.4

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

5.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.0

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

436.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.96

0.00

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

5.8

—

(44806420)

0.00

0.0

2.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

118.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.0

3.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.89

0.00

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.91

0.00

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.99

0.00

1.1

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.93

0.00

1.4

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DISPER and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_DISPER	6.697 [4.25, 10.56]	< 0.001
Birth year	1.001 [0.99, 1.01]	0.793

During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 656 females with F5_DISPER died.

Males

Parameter	HR [95% CI]	p-value
F5_DISPER	7.174 [6.34, 8.11]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 600 out of 3076 males with F5_DISPER died.

Mortality risk

Mortality risk for people of age

years, who have F5_DISPER.

N-year risk	Females	Males
1	0.715%	1.379%
5	4.774%	7.726%
10	11.51%	18.512%
15	21.053%	32.315%
20	34.369%	49.806%

Relationships between endpoints

↥

Index endpoint: F5_DISPER – Dissocial personality disorder

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dissocial personality disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints